Explore the detailed record of transactions filed by Warren Eric, Directeur Commercial. Insider active across 1 companies, notably Esperion Therapeutics, Inc.. Aggregated, 3 disclosures have been recorded. Total volume traded: €2k. The latest transaction was disclosed on 17 June 2022 — Cession. Regulator: SEC (Form 4). The full history is free.
3 of 3 declarations
Eric Warren serves as the Chief Commercial Officer of Esperion Therapeutics, Inc. He is responsible for leading the company's commercial initiatives, including sales development and marketing strategy. With significant experience in the pharmaceutical sector, he plays a key role in expanding Esperion's operations and establishing strong relationships with business partners. His expertise enables the company to effectively position itself in the market.